Asymmetry Capital Management’s Insmed INSM Stock Holding History

Asymmetry Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-113,875	Closed	-$2.72M	–	35
2019 Q4	$2.72M	Sell	113,875 -136,709	-55%	-$2.78M	4.87%	5
2019 Q3	$4.42M	Sell	250,584 -479,856	-66%	-$9.27M	9.47%	1
2019 Q2	$18.7M	Buy	730,440 +575,553	+372%	+$16M	10.13%	1
2019 Q1	$4.5M	Sell	154,887 -218,311	-58%	-$5.66M	7.52%	6
2018 Q4	$4.9M	Buy	373,198 +13,016	+4%	+$208K	13.53%	1
2018 Q3	$7.28M	Buy	360,182 +161,381	+81%	+$3.64M	6.73%	2
2018 Q2	$4.7M	Buy	198,801 +36,616	+23%	+$942K	4.62%	8
2018 Q1	$3.65M	Buy	162,185 +3,908	+2%	+$103K	4.57%	7
2017 Q4	$4.93M	Sell	158,277 -55,099	-26%	-$1.63M	6.7%	5
2017 Q3	$6.66M	Buy	+213,376	New	+$4.06M	7.72%	3

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Asymmetry Capital Management's INSM Position: Q1 2020 in Review

Asymmetry Capital Management sold out of Insmed (INSM) in Q1 2020, closing a stake of 113,875 shares — an estimated $2.72M sold.

Asymmetry Capital Management first reported a position in INSM in Q3 2017 and held it in 10 quarters. The position peaked at $18.7M in Q2 2019. 165 funds tracked by Wall St. Rank hold INSM as of Q1 2020.

Asymmetry Capital Management reported no remaining Insmed position as of Q1 2020 after selling out during the quarter.
Asymmetry Capital Management sold 113,875 Insmed shares in Q1 2020, an estimated $2.72M.
Asymmetry Capital Management first reported a position in Insmed in Q3 2017 and held it in 10 quarters.
Asymmetry Capital Management's Insmed position peaked at $18.7M in Q2 2019.
165 funds tracked by Wall St. Rank held Insmed as of Q1 2020.

Based on Asymmetry Capital Management's 13F filing for Q1 2020, filed 13 May 2020.